References
[1] Agarwal P, Devi LS. Otomycosis in a rural community attending a
tertiary care hospital: Assessment of risk factors and identification of
fungal and bacterial agents. J Clin Diagn Res 2017; 11:Dc14.
[2] Saniasiaya J, Salim R, Mohamad I, Harun A. Antifungal effect of
Malaysian aloe vera leaf extract on selected fungal species of
pathogenic otomycosis species in in vitro culture medium. Oman Med J
2017; 32:41.
[3] Tripathi RD, Srivastava HS, Dixit SN. A fungitoxic principle
from the leaves of Lawsonia inermis Lam. Experientia 1978; 34:51-2.
[4] Yaroko AA, Salim R, Mohamed Z, Mohamad I. Antifungal activity of
Malaysian Henna leaves extracts on pathogenic fungi of otomycosis. Int
Med J 2015; 22:389-91.
[5] Khattak SG, Gilani SN, Ikram M. Antipyretic studies on some
indigenous Pakistani medicinal plants. J Ethnopharmacol 1985; 14:45-51.
[6] Lal JB, Dutta SB. Constitution of the colouring matter of
Lawsonia alba or Indian Mehndi. J Indian Chem Soc 1933; 10:577-9.
[7] Bhatnagar SS, Santapau H, Desa JD, Maniar AC, Ghadially NC,
Solomon MJ et al. Biological activity of Indian medicinal plants. Part
I. Antibacterial, antitubercular and antifungal action. Indian J Med Res
1961; 49:799-813.
[8] Singh VK, Pandey DK. Fungitoxic studies on bark extract of
Lawsonia inermis against ringworm fungi. Hindustan Antibiot Bull 1989;
31:32-5.
[9] Rahmoun N, Boucherit-Otmani Z, Boucherit K, Benabdallah M,
Choukchou-Braham N. Antifungal activity of the Algerian Lawsonia inermis
(Henna). Pharm Biol 2013; 51:131-5.
[10] Salim R, Daud Mk, Narayanan Ms, Ab Rani A. Assessment of
vestibulotoxicity of Neem leaf (Azadirachta indica) in a rat animal
model. Indian J Otol 2020; 26:159.
[11] Al Deeb S, Al Moutaery K, Khan HA, Tariq M. Exacerbation of
iminodipropionitrileinduced behavioral toxicity, oxidative stress, and
vestibular hair cell degeneration by gentamicin in rats. Neurotoxicol
Teratol 2000; 22:213-20.
[12] Jadhav VJ, Pal M, Mishra GS. Etiological significance of
Candida albicans in otitis externa. Mycopathologia 2003; 156:313-15.
[13] Ho T, Vrabec JT, Yoo D, Coker NJ. Otomycosis: clinical features
and treatment implications. Otolaryngol Head Neck Surg 2006; 135:787-91.
[14] Vennewald I, Klemm E. Otomycosis: diagnosis and treatment. Clin
Dermatol 2010; 28:202-11.
[15] Kanafani ZA, Perfect JR. Resistance to antifungal agents:
mechanisms and clinical impact. Clin Infect Dis 2008; 46:120-8.
[16] Nemati S, Hassanzadeh R, Jahromi SK, Abadi AD. Otomycosis in
the north of Iran: common pathogens and resistance to antifungal agents.
Eur Arch Otorhinolaryngol 2014; 271:953-7.
[17] Rates SM. Plants as source of drugs. Toxicon 2001; 39:603-13.
[18] Hawkins JE, Keidel WD, Neff WD. Handbook of sensory physiology.
Drug ototoxicity 1976; 5:707.
[19] Almola Z. The inhibitory effect of Henna Lawsonia inermis
leaves on some fungi. Iraq Acad Sci J 2010; 10:501-10.
[20] Fetoni AR, Quaranta N, Marchese R, Cadoni G, Paludetti G, Sergi
B. The protective role of tiopronin in cisplatin ototoxicity in Wistar
rats. Int J Audiol 2004; 43:465-70.
[21] Rybak LP, Somani S. Ototoxicity. Amelioration by protective
agents. Ann N Y Acad Sci 1999; 884:143-51.
[22] Albuquerque AA, Rossato M, Oliveira JA, Hyppolito MA.
Understanding the anatomy of ears from guinea pigs and rats and its use
in basic otologic research. Braz J Otorhinolaryngol 2009; 75:43-49.
[23] Dutta S, Sengupta P. Men and mice: relating their ages. Life
sci 2016; 152:244-8.